(Q44852614)

English

Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK.

scientific article published in April 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 December 2017

Central nervous system toxicity of two adenoviral vectors encoding variants of the herpes simplex virus type 1 thymidine kinase: reduced cytotoxicity of a truncated HSV1-TK. (English)

1 reference

Europe PubMed Central

6 December 2017

vector-borne disease

0 references

0 references

1 reference

based on heuristic

inferred from title

Herpes simplex virus type 1

1 reference

based on heuristic

inferred from title

Maria G. Castro

11

1 reference

Europe PubMed Central

6 December 2017

author name string

Cowsill C

1

1 reference

Europe PubMed Central

6 December 2017

Southgate TD

2

1 reference

Europe PubMed Central

6 December 2017

Morrissey G

3

1 reference

Europe PubMed Central

6 December 2017

Dewey RA

4

1 reference

Europe PubMed Central

6 December 2017

Morelli AE

5

1 reference

Europe PubMed Central

6 December 2017

Maleniak TC

6

1 reference

Europe PubMed Central

6 December 2017

Forrest Z

7

1 reference

Europe PubMed Central

6 December 2017

Klatzmann D

8

1 reference

Europe PubMed Central

6 December 2017

Wilkinson GW

9

1 reference

Europe PubMed Central

6 December 2017

Löwenstein PR

10

1 reference

Europe PubMed Central

6 December 2017

publication date

1 April 2000

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

7

1 reference

Europe PubMed Central

6 December 2017

679-685

1 reference

Europe PubMed Central

6 December 2017

8

1 reference

Europe PubMed Central

6 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301147

0 references

Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

Mutant herpes simplex virus induced regression of tumors growing in immunocompetent rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

The TMC Worldwide Gene Therapy Enrollment Report, end 1996.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

The basic science of brain-tumour gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

21 January 2018

Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301147

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301147

1 reference

Europe PubMed Central

6 December 2017

1 reference

Europe PubMed Central

6 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44852614&oldid=1629312367"